ID

21927

Descrizione

The present pharmacokinetic study is designed to assess the pharmacokinetics of RSG XR as monotherapy in patients with mild Alzheimer's disease (AD) as such information will not be obtained from the current phase III trials . The study aims to enroll fourteen patients (seven of each APOE genotype). Each patient will receive a single oral dose of 4mg of RSG XR in the morning under fasted conditions and PK samples will be taken up to 36h. NOTE: If this is a SERIOUS ADVERSE EVENT (AE), DO NOT COMPLETE THIS FORM, got to the SAE section and complete the SAE form. GSK Source & Descriptions: https://clinicaltrials.gov/ct2/show/NCT00688207?term=NCT00688207&rank=1

collegamento

https://clinicaltrials.gov/ct2/show/NCT00688207?term=NCT00688207&rank=1

Keywords

versioni (2)
  1. 08/05/17 08/05/17 -
  2. 20/05/17 20/05/17 -
Caricato su

8 maggio 2017

DOI

Per favore, per richiedere un accesso.

Licenza

Creative Commons BY-NC 3.0
Commenti del modello :

Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.

Torna ai commenti del modello
Commenti del gruppo di articoli per :

Commenti dell'articolo per :

Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.

Non-Serious Adverse Events Mild Alzheimer's Disease to Assess the of Extended Release Formulation of Rosiglitazone NCT00688207 / GSK-AVA109941

Inglese

Non-Serious Adverse Events Mild Alzheimer's Disease to Assess the of Extended Release Formulation of Rosiglitazone NCT00688207 / GSK-AVA109941

1 moduli  
Non-Serious Adverse Event
Descrizione

Non-Serious Adverse Event

Alias
UMLS CUI-1
C1518404
Did the subject experience any non-serious adverse events during the study? If YES, record details below.
Descrizione

Non serious adverse event

Tipo di dati

boolean

Alias
UMLS CUI [1]
C1518404
Non-Serious Adverse Events (AE)
Descrizione

Non-Serious Adverse Events (AE)

Alias
UMLS CUI-1
C1518404
Event Diagnosis Only (if known) Otherwise Sign/Symptoms e.g. Headache
Descrizione

Non-Serious Adverse Event

Tipo di dati

text

Alias
UMLS CUI [1]
C1518404
Start Date (Day Month Year) (e.g. 25 JAN 03)
Descrizione

Start Date

Tipo di dati

date

Unità di misura
  • dd/MMM/yy
Alias
UMLS CUI [1]
C0808070
dd/MMM/yy
Start time (e.g. 13:25)
Descrizione

Start time

Tipo di dati

time

Unità di misura
  • hr:min
Alias
UMLS CUI [1]
C1301880
hr:min
Outcome
Descrizione

Outcome

Tipo di dati

integer

Alias
UMLS CUI [1]
C1705586
End Date e.g. 27 Jan 03
Descrizione

End Date

Tipo di dati

date

Unità di misura
  • hr:min
Alias
UMLS CUI [1]
C0806020
hr:min
End Time e.g. 10:20
Descrizione

End Time

Tipo di dati

time

Unità di misura
  • hr:min
Alias
UMLS CUI [1]
C1522314
hr:min
Frequency
Descrizione

Frequency

Tipo di dati

integer

Alias
UMLS CUI [1]
C3476109
Maximum Intensity
Descrizione

Maximum Intensity

Tipo di dati

integer

Alias
UMLS CUI [1,1]
C0518690
UMLS CUI [1,2]
C0877248
Action Taken with Investigational Product(s) as a Result of the Non-Serious AE
Descrizione

Action Taken with Investigational Product

Tipo di dati

integer

Alias
UMLS CUI [1]
C1704758
Withdrawal
Descrizione

Withdrawal

Tipo di dati

boolean

Alias
UMLS CUI [1]
C2349954
Relationship to Investigational Product(s) Is there a reasonable possibility that the AE may have been caused by the investigational product?
Descrizione

Relationship to Investigational Product

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0085978
UMLS CUI [1,2]
C0877248
Ritorna all'inizio della pagina

Similar models

Non-Serious Adverse Events Mild Alzheimer's Disease to Assess the of Extended Release Formulation of Rosiglitazone NCT00688207 / GSK-AVA109941

1 moduli
Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
Item Group
Non-Serious Adverse Event
C1518404 (UMLS CUI-1)
Non serious adverse event
Item
Did the subject experience any non-serious adverse events during the study? If YES, record details below.
boolean
C1518404 (UMLS CUI [1])
Item Group
Non-Serious Adverse Events (AE)
C1518404 (UMLS CUI-1)
Non-Serious Adverse Event
Item
Event Diagnosis Only (if known) Otherwise Sign/Symptoms e.g. Headache
text
C1518404 (UMLS CUI [1])
Start Date
Item
Start Date (Day Month Year) (e.g. 25 JAN 03)
date
C0808070 (UMLS CUI [1])
Start time
Item
Start time (e.g. 13:25)
time
C1301880 (UMLS CUI [1])
Item
Outcome
integer
C1705586 (UMLS CUI [1])
Outcome
Code List
Outcome
CL Item
Recovered/Resolved (1)
CL Item
Recovering/Resolving (2)
CL Item
Not recovered/Not resolved (3)
CL Item
Recovered/Resolved with sequelae (4)
End Date
Item
End Date e.g. 27 Jan 03
date
C0806020 (UMLS CUI [1])
End Time
Item
End Time e.g. 10:20
time
C1522314 (UMLS CUI [1])
Item
Frequency
integer
C3476109 (UMLS CUI [1])
Frequency
Code List
Frequency
CL Item
Single episode (1)
CL Item
Intermittent (2)
Item
Maximum Intensity
integer
C0518690 (UMLS CUI [1,1])
C0877248 (UMLS CUI [1,2])
Maximum Intensity
Code List
Maximum Intensity
CL Item
Mild (1)
CL Item
Moderate (2)
CL Item
Severe (3)
CL Item
Not applicable (4)
Item
Action Taken with Investigational Product(s) as a Result of the Non-Serious AE
integer
C1704758 (UMLS CUI [1])
Action Taken with Investigational Product
Code List
Action Taken with Investigational Product(s) as a Result of the Non-Serious AE
CL Item
Investigational product(s) (1)
CL Item
Dose reduced (2)
CL Item
Dose increased (3)
CL Item
Dose not changed (4)
CL Item
Dose interrupted (5)
CL Item
Not applicable (6)
Withdrawal
Item
Withdrawal
boolean
C2349954 (UMLS CUI [1])
Relationship to Investigational Product
Item
Relationship to Investigational Product(s) Is there a reasonable possibility that the AE may have been caused by the investigational product?
boolean
C0085978 (UMLS CUI [1,1])
C0877248 (UMLS CUI [1,2])
Ritorna all'inizio della pagina 

Contatto

Si prega di utilizzare questo modulo per feedback, domande e suggerimenti per miglioramenti.

I campi contrassegnati da * sono obbligatori.

Aiuto

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial